 Daniel Stephenson
Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocytes | 11 | 2025 | 672 | 1.250 |
Why?
| | Ceramides | 9 | 2024 | 112 | 1.160 |
Why?
| | Sphingolipids | 11 | 2024 | 71 | 1.130 |
Why?
| | Hemolysis | 6 | 2025 | 199 | 0.920 |
Why?
| | Pre-Eclampsia | 2 | 2023 | 185 | 0.850 |
Why?
| | Blood Preservation | 6 | 2025 | 271 | 0.780 |
Why?
| | Metabolomics | 7 | 2025 | 652 | 0.730 |
Why?
| | Eicosanoids | 7 | 2024 | 57 | 0.720 |
Why?
| | Biomarkers | 6 | 2024 | 3968 | 0.650 |
Why?
| | Premature Birth | 1 | 2023 | 313 | 0.640 |
Why?
| | Group IV Phospholipases A2 | 5 | 2023 | 47 | 0.580 |
Why?
| | Lipids | 5 | 2024 | 624 | 0.580 |
Why?
| | Cycloserine | 2 | 2024 | 5 | 0.460 |
Why?
| | Mice, Inbred NOD | 3 | 2024 | 588 | 0.440 |
Why?
| | Blood Donors | 2 | 2025 | 96 | 0.420 |
Why?
| | Erythrocyte Transfusion | 2 | 2025 | 181 | 0.410 |
Why?
| | Neural Stem Cells | 2 | 2024 | 143 | 0.400 |
Why?
| | Mice | 23 | 2025 | 16861 | 0.380 |
Why?
| | Anemia, Sickle Cell | 3 | 2024 | 254 | 0.370 |
Why?
| | Autophagy | 2 | 2025 | 267 | 0.340 |
Why?
| | Tears | 3 | 2024 | 28 | 0.320 |
Why?
| | Oxidative Stress | 6 | 2025 | 1268 | 0.310 |
Why?
| | Multiple Sclerosis | 2 | 2024 | 436 | 0.300 |
Why?
| | Aspirin | 2 | 2023 | 379 | 0.300 |
Why?
| | Erythrocyte Aging | 2 | 2025 | 13 | 0.300 |
Why?
| | Glycolysis | 3 | 2024 | 309 | 0.300 |
Why?
| | Animals | 26 | 2025 | 35219 | 0.300 |
Why?
| | Group VI Phospholipases A2 | 2 | 2024 | 6 | 0.300 |
Why?
| | Mice, Inbred C57BL | 9 | 2025 | 5408 | 0.300 |
Why?
| | Retinal Degeneration | 2 | 2024 | 37 | 0.280 |
Why?
| | Sphingomyelin Phosphodiesterase | 2 | 2024 | 22 | 0.270 |
Why?
| | Metabolome | 3 | 2024 | 338 | 0.270 |
Why?
| | Meibomian Glands | 2 | 2023 | 18 | 0.270 |
Why?
| | Cellular Senescence | 2 | 2025 | 181 | 0.260 |
Why?
| | Signal Transduction | 3 | 2024 | 4913 | 0.240 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 2 | 2022 | 42 | 0.240 |
Why?
| | Aging, Premature | 1 | 2025 | 13 | 0.240 |
Why?
| | Neuroacanthocytosis | 1 | 2025 | 5 | 0.240 |
Why?
| | Placenta | 2 | 2023 | 719 | 0.240 |
Why?
| | Carrier Proteins | 2 | 2020 | 740 | 0.240 |
Why?
| | Acute Kidney Injury | 2 | 2024 | 789 | 0.240 |
Why?
| | Proteostasis | 1 | 2025 | 27 | 0.240 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 1 | 2025 | 30 | 0.230 |
Why?
| | Polymorphism, Genetic | 2 | 2025 | 640 | 0.230 |
Why?
| | Macrophages | 2 | 2024 | 1478 | 0.230 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2025 | 56 | 0.230 |
Why?
| | Lipid Metabolism | 3 | 2024 | 497 | 0.230 |
Why?
| | Pyruvate Kinase | 1 | 2024 | 26 | 0.230 |
Why?
| | Glucose Transporter Type 1 | 1 | 2024 | 49 | 0.230 |
Why?
| | Vesicular Transport Proteins | 1 | 2025 | 84 | 0.230 |
Why?
| | Oleic Acid | 1 | 2024 | 39 | 0.230 |
Why?
| | Anaplasma phagocytophilum | 1 | 2024 | 3 | 0.230 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2024 | 65 | 0.220 |
Why?
| | Sphingosine | 1 | 2024 | 40 | 0.220 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2023 | 11 | 0.220 |
Why?
| | Blood Group Antigens | 1 | 2023 | 16 | 0.220 |
Why?
| | Carnitine | 1 | 2024 | 76 | 0.220 |
Why?
| | Uric Acid | 1 | 2025 | 161 | 0.210 |
Why?
| | Multiple Sclerosis, Chronic Progressive | 1 | 2023 | 26 | 0.210 |
Why?
| | Tandem Mass Spectrometry | 2 | 2024 | 515 | 0.210 |
Why?
| | Eye Injuries | 1 | 2024 | 46 | 0.210 |
Why?
| | Insulin-Secreting Cells | 2 | 2024 | 367 | 0.210 |
Why?
| | Calcium | 2 | 2019 | 1203 | 0.210 |
Why?
| | Dry Eye Syndromes | 1 | 2024 | 53 | 0.210 |
Why?
| | PTEN Phosphohydrolase | 1 | 2024 | 161 | 0.210 |
Why?
| | Fluoxetine | 1 | 2023 | 53 | 0.210 |
Why?
| | Arginine | 1 | 2024 | 264 | 0.210 |
Why?
| | Exercise Tolerance | 1 | 2025 | 273 | 0.200 |
Why?
| | Cholesterol | 1 | 2024 | 411 | 0.200 |
Why?
| | Humans | 31 | 2025 | 129212 | 0.200 |
Why?
| | Apoptosis | 4 | 2024 | 2501 | 0.200 |
Why?
| | Glutathione | 1 | 2024 | 348 | 0.200 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 229 | 0.200 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2024 | 3627 | 0.200 |
Why?
| | Inflammation | 6 | 2024 | 2723 | 0.200 |
Why?
| | Mast Cells | 1 | 2023 | 142 | 0.200 |
Why?
| | Mustard Gas | 1 | 2024 | 110 | 0.190 |
Why?
| | Light | 1 | 2024 | 353 | 0.190 |
Why?
| | Drosophila Proteins | 1 | 2023 | 185 | 0.190 |
Why?
| | Mice, Inbred BALB C | 1 | 2024 | 1243 | 0.190 |
Why?
| | Drosophila melanogaster | 1 | 2023 | 214 | 0.190 |
Why?
| | Neoplasm Proteins | 1 | 2025 | 424 | 0.190 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2024 | 856 | 0.190 |
Why?
| | Energy Metabolism | 2 | 2024 | 869 | 0.190 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2024 | 1056 | 0.180 |
Why?
| | Retinal Diseases | 1 | 2022 | 86 | 0.180 |
Why?
| | Head Injuries, Closed | 1 | 2021 | 50 | 0.180 |
Why?
| | Affective Symptoms | 1 | 2021 | 51 | 0.180 |
Why?
| | Movement Disorders | 1 | 2021 | 52 | 0.180 |
Why?
| | Wound Healing | 2 | 2022 | 303 | 0.180 |
Why?
| | Extracellular Vesicles | 1 | 2023 | 130 | 0.180 |
Why?
| | Macrophages, Peritoneal | 1 | 2020 | 91 | 0.170 |
Why?
| | Macular Degeneration | 1 | 2022 | 157 | 0.170 |
Why?
| | Female | 18 | 2025 | 68600 | 0.170 |
Why?
| | Vision Disorders | 1 | 2021 | 135 | 0.170 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2021 | 138 | 0.170 |
Why?
| | Cadherins | 1 | 2021 | 188 | 0.170 |
Why?
| | Hypoxia | 2 | 2023 | 1079 | 0.160 |
Why?
| | Antirheumatic Agents | 1 | 2022 | 278 | 0.160 |
Why?
| | Altitude | 1 | 2023 | 457 | 0.160 |
Why?
| | Kidney | 2 | 2024 | 1375 | 0.160 |
Why?
| | Reperfusion Injury | 1 | 2021 | 272 | 0.150 |
Why?
| | Cell Death | 1 | 2020 | 354 | 0.150 |
Why?
| | Muscle, Skeletal | 2 | 2025 | 1614 | 0.150 |
Why?
| | Phosphatidylcholines | 1 | 2019 | 146 | 0.150 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2023 | 573 | 0.150 |
Why?
| | Male | 17 | 2025 | 63491 | 0.150 |
Why?
| | Necrosis | 1 | 2018 | 232 | 0.140 |
Why?
| | Oxygen | 1 | 2022 | 911 | 0.140 |
Why?
| | Brain Concussion | 2 | 2024 | 548 | 0.140 |
Why?
| | Neutrophils | 1 | 2023 | 1202 | 0.140 |
Why?
| | Mass Spectrometry | 2 | 2020 | 716 | 0.140 |
Why?
| | Melanoma | 1 | 2024 | 729 | 0.140 |
Why?
| | Sepsis | 1 | 2023 | 571 | 0.140 |
Why?
| | Cell Differentiation | 1 | 2024 | 1899 | 0.130 |
Why?
| | Disease | 1 | 2017 | 95 | 0.130 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 243 | 0.130 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 981 | 0.130 |
Why?
| | Liver | 1 | 2024 | 1838 | 0.120 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2023 | 822 | 0.120 |
Why?
| | Cross-Sectional Studies | 2 | 2023 | 5057 | 0.120 |
Why?
| | Aging | 1 | 2024 | 1774 | 0.110 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4049 | 0.110 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 1049 | 0.110 |
Why?
| | Sphingomyelins | 2 | 2024 | 29 | 0.110 |
Why?
| | Pregnancy | 2 | 2023 | 6384 | 0.100 |
Why?
| | Lung Neoplasms | 2 | 2024 | 2339 | 0.100 |
Why?
| | Mice, Transgenic | 3 | 2025 | 2111 | 0.100 |
Why?
| | Brain | 1 | 2024 | 2664 | 0.100 |
Why?
| | Infant, Newborn | 1 | 2023 | 5753 | 0.090 |
Why?
| | Mammals | 2 | 2024 | 269 | 0.090 |
Why?
| | Adenosine Triphosphate | 2 | 2024 | 477 | 0.090 |
Why?
| | Thrombin | 2 | 2023 | 146 | 0.090 |
Why?
| | Retina | 2 | 2024 | 277 | 0.090 |
Why?
| | Mice, Knockout | 3 | 2025 | 2856 | 0.090 |
Why?
| | Asthma | 1 | 2024 | 2222 | 0.090 |
Why?
| | Neoplasms | 1 | 2024 | 2467 | 0.080 |
Why?
| | Adult | 7 | 2025 | 35464 | 0.080 |
Why?
| | Middle Aged | 6 | 2025 | 31075 | 0.080 |
Why?
| | Sex Characteristics | 2 | 2024 | 732 | 0.080 |
Why?
| | Sex Factors | 2 | 2025 | 1961 | 0.080 |
Why?
| | Proteomics | 2 | 2025 | 1061 | 0.070 |
Why?
| | Genome-Wide Association Study | 2 | 2024 | 1332 | 0.070 |
Why?
| | Fibroblasts | 2 | 2024 | 944 | 0.070 |
Why?
| | Recombinant Proteins | 2 | 2021 | 1303 | 0.070 |
Why?
| | Cell Movement | 2 | 2022 | 941 | 0.060 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2025 | 12 | 0.060 |
Why?
| | Aged | 4 | 2024 | 22030 | 0.060 |
Why?
| | Hydroxymethylglutaryl CoA Reductases | 1 | 2024 | 14 | 0.060 |
Why?
| | Erythroid Cells | 1 | 2024 | 9 | 0.060 |
Why?
| | Reticulocytes | 1 | 2024 | 18 | 0.060 |
Why?
| | Erythroblasts | 1 | 2024 | 15 | 0.060 |
Why?
| | Enzyme Activators | 1 | 2024 | 7 | 0.060 |
Why?
| | Phosphofructokinases | 1 | 2024 | 7 | 0.060 |
Why?
| | Lipid Peroxidation | 1 | 2025 | 151 | 0.060 |
Why?
| | Solute Carrier Family 22 Member 5 | 1 | 2024 | 9 | 0.060 |
Why?
| | Hexokinase | 1 | 2024 | 18 | 0.060 |
Why?
| | Erythropoiesis | 1 | 2024 | 51 | 0.060 |
Why?
| | Simvastatin | 1 | 2024 | 60 | 0.060 |
Why?
| | Serine C-Palmitoyltransferase | 1 | 2024 | 8 | 0.060 |
Why?
| | Cell Line, Tumor | 2 | 2024 | 3211 | 0.060 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 15 | 0.060 |
Why?
| | Photoreceptor Cells, Vertebrate | 1 | 2024 | 26 | 0.060 |
Why?
| | 2,3-Diphosphoglycerate | 1 | 2023 | 32 | 0.060 |
Why?
| | Lysophospholipids | 1 | 2024 | 72 | 0.050 |
Why?
| | Golgi Apparatus | 1 | 2024 | 99 | 0.050 |
Why?
| | Melanoma, Experimental | 1 | 2024 | 108 | 0.050 |
Why?
| | Mice, SCID | 1 | 2024 | 351 | 0.050 |
Why?
| | Eyelids | 1 | 2024 | 34 | 0.050 |
Why?
| | Depression | 2 | 2023 | 1302 | 0.050 |
Why?
| | Isoenzymes | 1 | 2024 | 302 | 0.050 |
Why?
| | Docosahexaenoic Acids | 1 | 2024 | 83 | 0.050 |
Why?
| | Mechlorethamine | 1 | 2024 | 63 | 0.050 |
Why?
| | Autocrine Communication | 1 | 2023 | 43 | 0.050 |
Why?
| | Cornea | 1 | 2024 | 128 | 0.050 |
Why?
| | Kynurenine | 1 | 2024 | 108 | 0.050 |
Why?
| | Feedback | 1 | 2023 | 160 | 0.050 |
Why?
| | Transplantation, Autologous | 1 | 2023 | 211 | 0.050 |
Why?
| | Pyruvates | 1 | 2022 | 23 | 0.050 |
Why?
| | Inosine | 1 | 2022 | 13 | 0.050 |
Why?
| | Iron | 1 | 2025 | 288 | 0.050 |
Why?
| | Quantitative Trait Loci | 1 | 2025 | 355 | 0.050 |
Why?
| | Enzyme Activation | 1 | 2024 | 811 | 0.050 |
Why?
| | Autophagosomes | 1 | 2022 | 19 | 0.050 |
Why?
| | Rabbits | 1 | 2024 | 778 | 0.050 |
Why?
| | Hydrogen Peroxide | 1 | 2024 | 317 | 0.050 |
Why?
| | Arachidonic Acids | 1 | 2022 | 55 | 0.050 |
Why?
| | Adipocytes | 1 | 2023 | 205 | 0.050 |
Why?
| | Sputum | 1 | 2024 | 301 | 0.050 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 55 | 0.050 |
Why?
| | Immunoglobulin E | 1 | 2023 | 329 | 0.050 |
Why?
| | Blood Transfusion | 1 | 2024 | 295 | 0.050 |
Why?
| | Chromatography, Liquid | 1 | 2023 | 415 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2019 | 2388 | 0.050 |
Why?
| | Phosphates | 1 | 2022 | 180 | 0.050 |
Why?
| | Lysosomes | 1 | 2022 | 138 | 0.050 |
Why?
| | Disease Resistance | 1 | 2021 | 31 | 0.050 |
Why?
| | Combined Modality Therapy | 1 | 2024 | 1202 | 0.050 |
Why?
| | Blotting, Western | 1 | 2024 | 1205 | 0.050 |
Why?
| | Oxidation-Reduction | 1 | 2025 | 1026 | 0.050 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 259 | 0.050 |
Why?
| | Brain Chemistry | 1 | 2021 | 117 | 0.050 |
Why?
| | Ischemia | 1 | 2024 | 406 | 0.040 |
Why?
| | Adenosine | 1 | 2022 | 224 | 0.040 |
Why?
| | Cell Survival | 1 | 2024 | 1085 | 0.040 |
Why?
| | Cisplatin | 1 | 2022 | 298 | 0.040 |
Why?
| | Tomography, Optical Coherence | 1 | 2022 | 186 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2024 | 826 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2024 | 478 | 0.040 |
Why?
| | Hemoglobins | 1 | 2022 | 339 | 0.040 |
Why?
| | Ketones | 1 | 2020 | 47 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2023 | 387 | 0.040 |
Why?
| | Naphthalenes | 1 | 2020 | 57 | 0.040 |
Why?
| | Thromboxane B2 | 1 | 2019 | 26 | 0.040 |
Why?
| | Hydroxyeicosatetraenoic Acids | 1 | 2019 | 42 | 0.040 |
Why?
| | Proteome | 1 | 2024 | 443 | 0.040 |
Why?
| | Immunotherapy | 1 | 2024 | 592 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2024 | 1424 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2021 | 238 | 0.040 |
Why?
| | Tensile Strength | 1 | 2019 | 93 | 0.040 |
Why?
| | Cations, Divalent | 1 | 2019 | 56 | 0.040 |
Why?
| | Brain Injuries, Traumatic | 1 | 2024 | 340 | 0.040 |
Why?
| | Cytosol | 1 | 2019 | 218 | 0.040 |
Why?
| | Dinoprostone | 1 | 2019 | 186 | 0.040 |
Why?
| | Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2018 | 14 | 0.040 |
Why?
| | Cytoplasm | 1 | 2019 | 263 | 0.040 |
Why?
| | Pilot Projects | 1 | 2024 | 1584 | 0.040 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2018 | 73 | 0.040 |
Why?
| | Cyclin-Dependent Kinase 2 | 1 | 2018 | 39 | 0.040 |
Why?
| | Cyclin-Dependent Kinase 4 | 1 | 2018 | 44 | 0.040 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2018 | 117 | 0.040 |
Why?
| | Cell Line | 1 | 2024 | 2777 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2019 | 361 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2019 | 282 | 0.040 |
Why?
| | Fear | 1 | 2021 | 348 | 0.040 |
Why?
| | Microscopy, Fluorescence | 1 | 2019 | 400 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2024 | 10189 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2019 | 387 | 0.040 |
Why?
| | Fatty Acids | 1 | 2020 | 425 | 0.030 |
Why?
| | Collagen | 1 | 2019 | 434 | 0.030 |
Why?
| | Models, Biological | 1 | 2024 | 1718 | 0.030 |
Why?
| | Proteins | 1 | 2023 | 939 | 0.030 |
Why?
| | Skin Neoplasms | 1 | 2024 | 823 | 0.030 |
Why?
| | Disease Progression | 1 | 2024 | 2622 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2019 | 582 | 0.030 |
Why?
| | Diet | 1 | 2024 | 1212 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2024 | 2071 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2024 | 3067 | 0.030 |
Why?
| | Mitochondria | 1 | 2022 | 875 | 0.030 |
Why?
| | Stroke | 1 | 2024 | 1064 | 0.030 |
Why?
| | Neurons | 1 | 2024 | 1493 | 0.030 |
Why?
| | Cell Cycle | 1 | 2018 | 590 | 0.030 |
Why?
| | Up-Regulation | 1 | 2018 | 837 | 0.030 |
Why?
| | Cytokines | 1 | 2023 | 2011 | 0.030 |
Why?
| | Skin | 1 | 2019 | 721 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1839 | 0.030 |
Why?
| | Phosphorylation | 1 | 2018 | 1710 | 0.030 |
Why?
| | Cohort Studies | 1 | 2024 | 5408 | 0.030 |
Why?
| | Protein Binding | 1 | 2019 | 2119 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2024 | 7061 | 0.020 |
Why?
| | Prospective Studies | 1 | 2024 | 7103 | 0.020 |
Why?
| | Child | 2 | 2023 | 20853 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2023 | 5387 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3074 | 0.020 |
Why?
| | Young Adult | 1 | 2024 | 12396 | 0.020 |
Why?
| | Adolescent | 1 | 2020 | 20371 | 0.010 |
Why?
|
|
Stephenson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|